In all patients (n = 897) we found that UCA1 score was superior to PSA only for detection of clinically insignificant, clinically significant, group 3 + 4 + 5 of WHO grade groups (Gleason score ≥4 + 3), and high‐risk prostate cancer with higher percentage. The gene discussed is UCA1; the disease is Familial prostate cancer.